1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Biologics and Biosimilars Consumption 2016-2026 2.1.2 Biologics and Biosimilars Consumption CAGR by Region 2.2 Biologics and Biosimilars Segment by Type 2.2.1 Monoclonal Antibodies 2.2.2 Interferon 2.2.3 Erythropoietin 2.2.4 Insulin 2.2.5 Vaccines 2.2.6 Others 2.3 Biologics and Biosimilars Sales by Type 2.3.1 Global Biologics and Biosimilars Sales Market Share by Type (2016-2021) 2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2016-2021) 2.3.3 Global Biologics and Biosimilars Sale Price by Type (2016-2021) 2.4 Biologics and Biosimilars Segment by Application 2.4.1 Tumor 2.4.2 Diabetes 2.4.3 Cardiovascular 2.4.4 Hemophilia 2.4.5 Others 2.5 Biologics and Biosimilars Sales by Application 2.5.1 Global Biologics and Biosimilars Sale Market Share by Application (2016-2021) 2.5.2 Global Biologics and Biosimilars Revenue and Market Share by Application (2016-2021) 2.5.3 Global Biologics and Biosimilars Sale Price by Application (2016-2021) 3 Global Biologics and Biosimilars by Company 3.1 Global Biologics and Biosimilars Sales Market Share by Company 3.1.1 Global Biologics and Biosimilars Sales by Company (2019-2021) 3.1.2 Global Biologics and Biosimilars Sales Market Share by Company (2019-2021) 3.2 Global Biologics and Biosimilars Revenue Market Share by Company 3.2.1 Global Biologics and Biosimilars Revenue by Company (2019-2021) 3.2.2 Global Biologics and Biosimilars Revenue Market Share by Company (2019-2021) 3.3 Global Biologics and Biosimilars Sale Price by Company 3.4 Global Manufacturers Biologics and Biosimilars Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Biologics and Biosimilars Product Location Distribution 3.4.2 Players Biologics and Biosimilars Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Biologics and Biosimilars by Region 4.1 Global Biologics and Biosimilars by Region 4.1.1 Global Biologics and Biosimilars Sales by Region 4.1.2 Global Biologics and Biosimilars Revenue by Region 4.2 Americas Biologics and Biosimilars Sales Growth 4.3 APAC Biologics and Biosimilars Sales Growth 4.4 Europe Biologics and Biosimilars Sales Growth 4.5 Middle East & Africa Biologics and Biosimilars Sales Growth 5 Americas 5.1 Americas Biologics and Biosimilars Sales by Country 5.1.1 Americas Biologics and Biosimilars Sales by Country (2016-2021) 5.1.2 Americas Biologics and Biosimilars Revenue by Country (2016-2021) 5.2 Americas Biologics and Biosimilars Sales by Type 5.3 Americas Biologics and Biosimilars Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Biologics and Biosimilars Sales by Region 6.1.1 APAC Biologics and Biosimilars Sales by Region (2016-2021) 6.1.2 APAC Biologics and Biosimilars Revenue by Region (2016-2021) 6.2 APAC Biologics and Biosimilars Sales by Type 6.3 APAC Biologics and Biosimilars Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Biologics and Biosimilars by Country 7.1.1 Europe Biologics and Biosimilars Sales by Country (2016-2021) 7.1.2 Europe Biologics and Biosimilars Revenue by Country (2016-2021) 7.2 Europe Biologics and Biosimilars Sales by Type 7.3 Europe Biologics and Biosimilars Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Biologics and Biosimilars by Country 8.1.1 Middle East & Africa Biologics and Biosimilars Sales by Country (2016-2021) 8.1.2 Middle East & Africa Biologics and Biosimilars Revenue by Country (2016-2021) 8.2 Middle East & Africa Biologics and Biosimilars Sales by Type 8.3 Middle East & Africa Biologics and Biosimilars Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Biologics and Biosimilars Distributors 10.3 Biologics and Biosimilars Customer 11 Global Biologics and Biosimilars Market Forecast 11.1 Global Biologics and Biosimilars Forecast by Region 11.1.1 Global Biologics and Biosimilars Forecast by Regions (2021-2026) 11.2.2 Global Biologics and Biosimilars Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Biologics and Biosimilars Forecast by Type 11.7 Global Biologics and Biosimilars Forecast by Application 12 Key Players Analysis 12.1 Roche 12.1.1 Roche Company Information 12.1.2 Roche Biologics and Biosimilars Product Offered 12.1.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Roche Main Business Overview 12.1.5 Roche Latest Developments 12.2 Amgen 12.2.1 Amgen Company Information 12.2.2 Amgen Biologics and Biosimilars Product Offered 12.2.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Amgen Main Business Overview 12.2.5 Amgen Latest Developments 12.3 AbbVie 12.3.1 AbbVie Company Information 12.3.2 AbbVie Biologics and Biosimilars Product Offered 12.3.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 AbbVie Main Business Overview 12.3.5 AbbVie Latest Developments 12.4 Sanofi-Aventis 12.4.1 Sanofi-Aventis Company Information 12.4.2 Sanofi-Aventis Biologics and Biosimilars Product Offered 12.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Sanofi-Aventis Main Business Overview 12.4.5 Sanofi-Aventis Latest Developments 12.5 Johnson & Johnson 12.5.1 Johnson & Johnson Company Information 12.5.2 Johnson & Johnson Biologics and Biosimilars Product Offered 12.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Johnson & Johnson Main Business Overview 12.5.5 Johnson & Johnson Latest Developments 12.6 Pfizer 12.6.1 Pfizer Company Information 12.6.2 Pfizer Biologics and Biosimilars Product Offered 12.6.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 Pfizer Main Business Overview 12.6.5 Pfizer Latest Developments 12.7 Novo Nordisk 12.7.1 Novo Nordisk Company Information 12.7.2 Novo Nordisk Biologics and Biosimilars Product Offered 12.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 Novo Nordisk Main Business Overview 12.7.5 Novo Nordisk Latest Developments 12.8 Eli Lilly 12.8.1 Eli Lilly Company Information 12.8.2 Eli Lilly Biologics and Biosimilars Product Offered 12.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 Eli Lilly Main Business Overview 12.8.5 Eli Lilly Latest Developments 12.9 Novartis 12.9.1 Novartis Company Information 12.9.2 Novartis Biologics and Biosimilars Product Offered 12.9.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.9.4 Novartis Main Business Overview 12.9.5 Novartis Latest Developments 12.10 Merck 12.10.1 Merck Company Information 12.10.2 Merck Biologics and Biosimilars Product Offered 12.10.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.10.4 Merck Main Business Overview 12.10.5 Merck Latest Developments 12.11 3sbio 12.11.1 3sbio Company Information 12.11.2 3sbio Biologics and Biosimilars Product Offered 12.11.3 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.11.4 3sbio Main Business Overview 12.11.5 3sbio Latest Developments 12.12 Changchun High Tech 12.12.1 Changchun High Tech Company Information 12.12.2 Changchun High Tech Biologics and Biosimilars Product Offered 12.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.12.4 Changchun High Tech Main Business Overview 12.12.5 Changchun High Tech Latest Developments 12.13 CP Guojian 12.13.1 CP Guojian Company Information 12.13.2 CP Guojian Biologics and Biosimilars Product Offered 12.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.13.4 CP Guojian Main Business Overview 12.13.5 CP Guojian Latest Developments 12.14 Biotech 12.14.1 Biotech Company Information 12.14.2 Biotech Biologics and Biosimilars Product Offered 12.14.3 Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.14.4 Biotech Main Business Overview 12.14.5 Biotech Latest Developments 12.15 Gelgen 12.15.1 Gelgen Company Information 12.15.2 Gelgen Biologics and Biosimilars Product Offered 12.15.3 Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.15.4 Gelgen Main Business Overview 12.15.5 Gelgen Latest Developments 12.16 Innovent 12.16.1 Innovent Company Information 12.16.2 Innovent Biologics and Biosimilars Product Offered 12.16.3 Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.16.4 Innovent Main Business Overview 12.16.5 Innovent Latest Developments 12.17 Dong Bao 12.17.1 Dong Bao Company Information 12.17.2 Dong Bao Biologics and Biosimilars Product Offered 12.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.17.4 Dong Bao Main Business Overview 12.17.5 Dong Bao Latest Developments 12.18 Ganlee 12.18.1 Ganlee Company Information 12.18.2 Ganlee Biologics and Biosimilars Product Offered 12.18.3 Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.18.4 Ganlee Main Business Overview 12.18.5 Ganlee Latest Developments 12.19 United Laboratories 12.19.1 United Laboratories Company Information 12.19.2 United Laboratories Biologics and Biosimilars Product Offered 12.19.3 United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021) 12.19.4 United Laboratories Main Business Overview 12.19.5 United Laboratories Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Biologics and Biosimilars Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Monoclonal Antibodies Table 3. Major Players of Interferon Table 4. Major Players of Erythropoietin Table 5. Major Players of Insulin Table 6. Major Players of Vaccines Table 7. Major Players of Others Table 8. Global Biologics and Biosimilars Sales by Type (2016-2021) & (K Units) Table 9. Global Biologics and Biosimilars Sales Market Share by Type (2016-2021) Table 10. Global Biologics and Biosimilars Revenue by Type (2016-2021) & ($ million) Table 11. Global Biologics and Biosimilars Revenue Market Share by Type (2016-2021) Table 12. Global Biologics and Biosimilars Sale Price by Type (2016-2021) Table 13. Global Biologics and Biosimilars Sales by Application (2016-2021) & (K Units) Table 14. Global Biologics and Biosimilars Sales Market Share by Application (2016-2021) Table 15. Global Biologics and Biosimilars Value by Application (2016-2021) Table 16. Global Biologics and Biosimilars Revenue Market Share by Application (2016-2021) Table 17. Global Biologics and Biosimilars Sale Price by Application (2016-2021) Table 18. Global Biologics and Biosimilars Sales by Company (2019-2021) & (K Units) Table 19. Global Biologics and Biosimilars Sales Market Share by Company (2019-2021) Table 20. Global Biologics and Biosimilars Revenue by Company (2019-2021) ($ Millions) Table 21. Global Biologics and Biosimilars Revenue Market Share by Company (2019-2021) Table 22. Global Biologics and Biosimilars Sale Price by Company (2019-2021) Table 23. Key Manufacturers Biologics and Biosimilars Producing Area Distribution and Sales Area Table 24. Players Biologics and Biosimilars Products Offered Table 25. Biologics and Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 26. New Products and Potential Entrants Table 27. Mergers & Acquisitions, Expansion Table 28. Global Biologics and Biosimilars Sales by Region (2016-2021) (K Units) Table 29. Global Biologics and Biosimilars Sales Market Share by Region (2016-2021) Table 30. Global Biologics and Biosimilars Revenue by Region (2016-2021) & ($ Millions) Table 31. Global Biologics and Biosimilars Revenue Market Share by Region (2016-2021) Table 32. Americas Biologics and Biosimilars Sales by Country (2016-2021) & (K Units) Table 33. Americas Biologics and Biosimilars Sales Market Share by Country (2016-2021) Table 34. Americas Biologics and Biosimilars Revenue by Country (2016-2021) & ($ Millions) Table 35. Americas Biologics and Biosimilars Revenue Market Share by Country (2016-2021) Table 36. Americas Biologics and Biosimilars Sales by Type (2016-2021) & (K Units) Table 37. Americas Biologics and Biosimilars Sales Market Share by Type (2016-2021) Table 38. Americas Biologics and Biosimilars Sales by Application (2016-2021) & (K Units) Table 39. Americas Biologics and Biosimilars Sales Market Share by Application (2016-2021) Table 40. APAC Biologics and Biosimilars Sales by Region (2016-2021) & (K Units) Table 41. APAC Biologics and Biosimilars Sales Market Share by Region (2016-2021) Table 42. APAC Biologics and Biosimilars Revenue by Region (2016-2021) & ($ Millions) Table 43. APAC Biologics and Biosimilars Revenue Market Share by Region (2016-2021) Table 44. APAC Biologics and Biosimilars Sales by Type (2016-2021) & (K Units) Table 45. APAC Biologics and Biosimilars Sales Market Share by Type (2016-2021) Table 46. APAC Biologics and Biosimilars Sales by Application (2016-2021) & (K Units) Table 47. APAC Biologics and Biosimilars Sales Market Share by Application (2016-2021) Table 48. Europe Biologics and Biosimilars Sales by Country (2016-2021) & (K Units) Table 49. Europe Biologics and Biosimilars Sales Market Share by Country (2016-2021) Table 50. Europe Biologics and Biosimilars Revenue by Country (2016-2021) & ($ Millions) Table 51. Europe Biologics and Biosimilars Revenue Market Share by Country (2016-2021) Table 52. Europe Biologics and Biosimilars Sales by Type (2016-2021) & (K Units) Table 53. Europe Biologics and Biosimilars Sales Market Share by Type (2016-2021) Table 54. Europe Biologics and Biosimilars Sales by Application (2016-2021) & (K Units) Table 55. Europe Biologics and Biosimilars Sales Market Share by Application (2016-2021) Table 56. Middle East & Africa Biologics and Biosimilars Sales by Country (2016-2021) & (K Units) Table 57. Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2016-2021) Table 58. Middle East & Africa Biologics and Biosimilars Revenue by Country (2016-2021) & ($ Millions) Table 59. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2016-2021) Table 60. Middle East & Africa Biologics and Biosimilars Sales by Type (2016-2021) & (K Units) Table 61. Middle East & Africa Biologics and Biosimilars Sales Market Share by Type (2016-2021) Table 62. Middle East & Africa Biologics and Biosimilars Sales by Application (2016-2021) & (K Units) Table 63. Middle East & Africa Biologics and Biosimilars Sales Market Share by Application (2016-2021) Table 64. Key and Potential Regions of Biologics and Biosimilars Table 65. Key Application and Potential Industries of Biologics and Biosimilars Table 66. Key Challenges of Biologics and Biosimilars Table 67. Key Trends of Biologics and Biosimilars Table 68. Biologics and Biosimilars Distributors List Table 69. Biologics and Biosimilars Customer List Table 70. Global Biologics and Biosimilars Sales Forecast by Region (2021-2026) & (K Units) Table 71. Global Biologics and Biosimilars Consumption Market Forecast by Region Table 72. Global Biologics and Biosimilars Revenue Forecast by Region (2021-2026) & ($ millions) Table 73. Global Biologics and Biosimilars Revenue Market Share Forecast by Region (2021-2026) Table 74. Americas Biologics and Biosimilars Sales Forecast by Country (2021-2026) & (K Units) Table 75. Americas Biologics and Biosimilars Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. APAC Biologics and Biosimilars Sales Forecast by Region (2021-2026) & (K Units) Table 77. APAC Biologics and Biosimilars Revenue Forecast by Region (2021-2026) & ($ millions) Table 78. Europe Biologics and Biosimilars Sales Forecast by Country (2021-2026) & (K Units) Table 79. Europe Biologics and Biosimilars Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Middle East & Africa Biologics and Biosimilars Sales Forecast by Country (2021-2026) & (K Units) Table 81. Middle East & Africa Biologics and Biosimilars Revenue Forecast by Country (2021-2026) & ($ millions) Table 82. Global Biologics and Biosimilars Sales Forecast by Type (2021-2026) & (K Units) Table 83. Global Biologics and Biosimilars Sales Market Share Forecast by Type (2021-2026) Table 84. Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026) & ($ Millions) Table 85. Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2021-2026) Table 86. Global Biologics and Biosimilars Sales Forecast by Application (2021-2026) & (K Units) Table 87. Global Biologics and Biosimilars Sales Market Share Forecast by Application (2021-2026) Table 88. Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026) & ($ Millions) Table 89. Global Biologics and Biosimilars Revenue Market Share Forecast by Application (2021-2026) Table 90. Roche Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 91. Roche Biologics and Biosimilars Product Offered Table 92. Roche Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 93. Roche Main Business Table 94. Roche Latest Developments Table 95. Amgen Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 96. Amgen Biologics and Biosimilars Product Offered Table 97. Amgen Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 98. Amgen Main Business Table 99. Amgen Latest Developments Table 100. AbbVie Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 101. AbbVie Biologics and Biosimilars Product Offered Table 102. AbbVie Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 103. AbbVie Main Business Table 104. AbbVie Latest Developments Table 105. Sanofi-Aventis Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 106. Sanofi-Aventis Biologics and Biosimilars Product Offered Table 107. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 108. Sanofi-Aventis Main Business Table 109. Sanofi-Aventis Latest Developments Table 110. Johnson & Johnson Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 111. Johnson & Johnson Biologics and Biosimilars Product Offered Table 112. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 113. Johnson & Johnson Main Business Table 114. Johnson & Johnson Latest Developments Table 115. Pfizer Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 116. Pfizer Biologics and Biosimilars Product Offered Table 117. Pfizer Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 118. Pfizer Main Business Table 119. Pfizer Latest Developments Table 120. Novo Nordisk Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 121. Novo Nordisk Biologics and Biosimilars Product Offered Table 122. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 123. Novo Nordisk Main Business Table 124. Novo Nordisk Latest Developments Table 125. Eli Lilly Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 126. Eli Lilly Biologics and Biosimilars Product Offered Table 127. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 128. Eli Lilly Main Business Table 129. Eli Lilly Latest Developments Table 130. Novartis Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 131. Novartis Biologics and Biosimilars Product Offered Table 132. Novartis Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 133. Novartis Main Business Table 134. Novartis Latest Developments Table 135. Merck Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 136. Merck Biologics and Biosimilars Product Offered Table 137. Merck Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 138. Merck Main Business Table 139. Merck Latest Developments Table 140. 3sbio Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 141. 3sbio Biologics and Biosimilars Product Offered Table 142. 3sbio Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 143. 3sbio Main Business Table 144. 3sbio Latest Developments Table 145. Changchun High Tech Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 146. Changchun High Tech Biologics and Biosimilars Product Offered Table 147. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 148. Changchun High Tech Main Business Table 149. Changchun High Tech Latest Developments Table 150. CP Guojian Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 151. CP Guojian Biologics and Biosimilars Product Offered Table 152. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 153. CP Guojian Main Business Table 154. CP Guojian Latest Developments Table 155. Biotech Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 156. Biotech Biologics and Biosimilars Product Offered Table 157. Biotech Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 158. Biotech Main Business Table 159. Biotech Latest Developments Table 160. Gelgen Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 161. Gelgen Biologics and Biosimilars Product Offered Table 162. Gelgen Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 163. Gelgen Main Business Table 164. Gelgen Latest Developments Table 165. Innovent Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 166. Innovent Biologics and Biosimilars Product Offered Table 167. Innovent Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 168. Innovent Main Business Table 169. Innovent Latest Developments Table 170. Dong Bao Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 171. Dong Bao Biologics and Biosimilars Product Offered Table 172. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 173. Dong Bao Main Business Table 174. Dong Bao Latest Developments Table 175. Ganlee Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 176. Ganlee Biologics and Biosimilars Product Offered Table 177. Ganlee Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 178. Ganlee Main Business Table 179. Ganlee Latest Developments Table 180. United Laboratories Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors Table 181. United Laboratories Biologics and Biosimilars Product Offered Table 182. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 183. United Laboratories Main Business Table 184. United Laboratories Latest Developments List of Figures Figure 1. Picture of Biologics and Biosimilars Figure 2. Biologics and Biosimilars Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Biologics and Biosimilars Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Biologics and Biosimilars Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Biologics and Biosimilars Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Monoclonal Antibodies Figure 10. Product Picture of Interferon Figure 11. Product Picture of Erythropoietin Figure 12. Product Picture of Insulin Figure 13. Product Picture of Vaccines Figure 14. Product Picture of Others Figure 15. Global Biologics and Biosimilars Sales Market Share by Type in 2020 Figure 16. Global Biologics and Biosimilars Revenue Market Share by Type (2016-2021) Figure 17. Biologics and Biosimilars Consumed in Tumor Figure 18. Global Biologics and Biosimilars Market: Tumor (2016-2021) & (K Units) Figure 19. Biologics and Biosimilars Consumed in Diabetes Figure 20. Global Biologics and Biosimilars Market: Diabetes (2016-2021) & (K Units) Figure 21. Biologics and Biosimilars Consumed in Cardiovascular Figure 22. Global Biologics and Biosimilars Market: Cardiovascular (2016-2021) & (K Units) Figure 23. Biologics and Biosimilars Consumed in Hemophilia Figure 24. Global Biologics and Biosimilars Market: Hemophilia (2016-2021) & (K Units) Figure 25. Biologics and Biosimilars Consumed in Others Figure 26. Global Biologics and Biosimilars Market: Others (2016-2021) & (K Units) Figure 27. Global Biologics and Biosimilars Sales Market Share by Application (2016-2021) Figure 28. Global Biologics and Biosimilars Revenue Market Share by Application in 2020 Figure 29. Biologics and Biosimilars Revenue Market by Company in 2020 ($ Million) Figure 30. Global Biologics and Biosimilars Revenue Market Share by Company in 2020 Figure 31. Global Biologics and Biosimilars Sales Market Share by Regions (2016-2021) Figure 32. Global Biologics and Biosimilars Revenue Market Share by Region in 2020 Figure 33. Americas Biologics and Biosimilars Sales 2016-2021 (K Units) Figure 34. Americas Biologics and Biosimilars Revenue 2016-2021 ($ Millions) Figure 35. APAC Biologics and Biosimilars Sales 2016-2021 (K Units) Figure 36. APAC Biologics and Biosimilars Revenue 2016-2021 ($ Millions) Figure 37. Europe Biologics and Biosimilars Sales 2016-2021 (K Units) Figure 38. Europe Biologics and Biosimilars Revenue 2016-2021 ($ Millions) Figure 39. Middle East & Africa Biologics and Biosimilars Sales 2016-2021 (K Units) Figure 40. Middle East & Africa Biologics and Biosimilars Revenue 2016-2021 ($ Millions) Figure 41. Americas Biologics and Biosimilars Sales Market Share by Country in 2020 Figure 42. Americas Biologics and Biosimilars Revenue Market Share by Country in 2020 Figure 43. Americas Biologics and Biosimilars Sales Market Share by Type in 2020 Figure 44. Americas Biologics and Biosimilars Sales Market Share by Application in 2020 Figure 45. United States Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 46. Canada Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 47. Mexico Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 48. Brazil Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 49. APAC Biologics and Biosimilars Sales Market Share by Region in 2020 Figure 50. APAC Biologics and Biosimilars Revenue Market Share by Regions in 2020 Figure 51. APAC Biologics and Biosimilars Sales Market Share by Type in 2020 Figure 52. APAC Biologics and Biosimilars Sales Market Share by Application in 2020 Figure 53. China Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 54. Japan Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 55. Korea Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 56. Southeast Asia Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 57. India Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 58. Australia Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 59. Europe Biologics and Biosimilars Sales Market Share by Country in 2020 Figure 60. Europe Biologics and Biosimilars Revenue Market Share by Country in 2020 Figure 61. Europe Biologics and Biosimilars Sales Market Share by Type in 2020 Figure 62. Europe Biologics and Biosimilars Sales Market Share by Application in 2020 Figure 63. Germany Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 64. France Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 65. UK Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 66. Italy Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 67. Russia Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 68. Middle East & Africa Biologics and Biosimilars Sales Market Share by Country in 2020 Figure 69. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country in 2020 Figure 70. Middle East & Africa Biologics and Biosimilars Sales Market Share by Type in 2020 Figure 71. Middle East & Africa Biologics and Biosimilars Sales Market Share by Application in 2020 Figure 72. Egypt Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 73. South Africa Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 74. Israel Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 75. Turkey Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 76. GCC Country Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions) Figure 77. Channels of Distribution Figure 78. Distributors Profiles